Get the Stockscreener App
1.59
0.63%
-0.01
After Hours:
1.65
0.06
+3.77%
Calidi Biotherapeutics Inc stock is traded at $1.59, with a volume of 305.10K.
It is down -0.63% in the last 24 hours and down -3.64% over the past month.
Calidi Biotherapeutics Inc., a clinical stage immuno-oncology company, engages in developing immunotherapies for the treatment of cancer. It engages in advancing a potent allogeneic stem cell capable of carrying an anti-tumor payload for use in multiple oncology indications, including high-grade gliomas and solid tumors. The company's cell-based delivery platforms are designed to protect, amplify, and potentiate oncolytic viruses leading to enhanced efficacy and improved patient safety. Its pipeline of products candidates in the clinic includes NeuroNova that are allogeneic neural stem cells loaded with an oncolytic adenovirus for the treatment of high-grade gliomas; and SuperNova, which are allogeneic adipose-derived mesenchymal stem cells loaded with tumor-selective CAL1 oncolytic vaccinia virus for the treatment of advanced metastatic solid tumors. The company was founded in 2014 and is headquartered in San Diego, California.
See More
Previous Close:
$1.60
Open:
$1.62
24h Volume:
305.10K
Relative Volume:
0.21
Market Cap:
$8.56M
Revenue:
-
Net Income/Loss:
$-23.36M
P/E Ratio:
-2.158
EPS:
-0.7368
Net Cash Flow:
-
1W Performance:
-2.45%
1M Performance:
-3.64%
6M Performance:
-68.90%
1Y Performance:
-87.73%
1-Day Range:
$1.5843
$1.67
1-Week Range:
$1.55
$1.68
52-Week Range:
$1.41
$46.68
Calidi Biotherapeutics Inc Stock (CLDI) Company Profile
Name
Calidi Biotherapeutics Inc
Sector
Industry
Phone
(858) 794-9600
Address
4475 Executive Drive, Suite 200, San Diego
Compare CLDI with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CLDI
Calidi Biotherapeutics Inc
|
1.59 | 8.56M | 0 | -23.36M | 0 | -0.7368 |
|
VRTX
Vertex Pharmaceuticals Inc
|
421.15 | 105.19B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
450.68 | 60.24B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
563.86 | 61.82B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
798.94 | 49.09B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
351.09 | 37.52B | 4.56B | -176.77M | 225.30M | -1.7177 |
Calidi Biotherapeutics Inc Stock (CLDI) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-22-23 | Initiated | H.C. Wainwright | Buy |
| Oct-09-23 | Initiated | Robert W. Baird | Outperform |
Calidi Biotherapeutics Inc Stock (CLDI) Latest News
What’s the recovery path for long term holders of Calidi Biotherapeutics Inc.Gap Down & Long-Term Safe Investment Plans - newser.com
Will Calidi Biotherapeutics Inc. stock maintain growth storyShort Setup & Accurate Entry/Exit Alerts - newser.com
Why ETFs are accumulating Calidi Biotherapeutics Inc. stockIPO Watch & Low Drawdown Investment Strategies - newser.com
Will Calidi Biotherapeutics Inc. stock keep outperforming rivalsWeekly Trade Analysis & Reliable Trade Execution Plans - newser.com
How rising interest rates impact Calidi Biotherapeutics Inc. stockWeekly Market Summary & Reliable Intraday Trade Alerts - newser.com
Will Calidi Biotherapeutics Inc. continue its uptrendWeekly Market Report & Low Risk Entry Point Guides - newser.com
Is it time to cut losses on Calidi Biotherapeutics Inc.Take Profit & Precise Swing Trade Entry Alerts - newser.com
Visual analytics tools that track Calidi Biotherapeutics Inc. performanceQuarterly Market Review & Community Consensus Trade Signals - newser.com
How Calidi Biotherapeutics Inc. stock reacts to monetary easing2025 Macro Impact & Safe Entry Momentum Stock Tips - newser.com
Using Ichimoku Cloud for Calidi Biotherapeutics Inc. technicalsAnalyst Upgrade & Low Drawdown Trading Strategies - newser.com
How institutional ownership impacts Calidi Biotherapeutics Inc. stockQuarterly Earnings Summary & Low Risk Entry Point Guides - newser.com
Will Calidi Biotherapeutics Inc. stock justify high valuationProfit Target & Weekly Momentum Stock Picks - newser.com
Published on: 2025-09-29 23:45:14 - newser.com
Calidi Biotherapeutics to Present at the second annual Oncology Venture, Innovation, and Partnering Summit in Boston - GlobeNewswire
Analyzing Calidi Biotherapeutics Inc. with risk reward ratio chartsIPO Watch & Low Drawdown Investment Strategies - newser.com
Can momentum traders help lift Calidi Biotherapeutics Inc.Rate Cut & Expert Curated Trade Setup Alerts - newser.com
Calidi Biotherapeutics Inc Stock (CLDI) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.05%
4.71%
Cap:
|
Volume (24h):